PT Medela Potentia Tbk (IDX:MDLA)

Indonesia · Delayed Price · Currency is IDR

204.00

-2.00 (-0.97%)

Jun 19, 2026, 4:02 PM WIB

-1.92% (1Y)

Market Cap	2.86T +5.8%
Revenue (ttm)	15.03T +6.0%
Net Income	398.64B +17.1%
EPS	28.72 -18.4%
Shares Out	14.01B
PE Ratio	7.10
Forward PE	7.03
Dividend	9.80 (4.80%)
Ex-Dividend Date	May 25, 2026

Volume	882,700
Open	206.00
Previous Close	206.00
Day's Range	202.00 - 210.00
52-Week Range	175.00 - 318.00
Beta	n/a
Analysts	Buy
Price Target	297.00 (+45.59%)
Earnings Date	Jul 29, 2026

About PT Medela Potentia Tbk

PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its products to retailers, end consumers, and patients. PT Medela Potentia Tb... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2011

Employees 2,202

Stock Exchange Indonesia Stock Exchange

Ticker Symbol MDLA

Full Company Profile

Financial Performance

In 2025, PT Medela Potentia Tbk's revenue was 14.89 trillion, an increase of 2.24% compared to the previous year's 14.57 trillion. Earnings were 392.27 billion, an increase of 13.69%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for MDLA stock is "Buy." The 12-month stock price target is Rp 297.00, which is an increase of 45.59% from the latest price.

Price Target

Rp 297.00

(45.59% upside)

Analyst Consensus: Buy

Stock Forecasts